ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with functioning across multiple settings. Onset is in childhood, though many adults are diagnosed for the first time in adulthood.

Overview

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition involving differences in attention regulation, executive function, impulse control, and activity level. It is one of the most common neurodevelopmental conditions, with prevalence estimates of approximately 5% to 7% of children and 2.5% to 4.4% of adults worldwide.

The DSM-5-TR recognizes three presentations: predominantly inattentive (formerly ADD), predominantly hyperactive-impulsive, and combined. Symptoms must be present before age 12, occur across two or more settings, and cause clinically significant impairment in social, academic, or occupational functioning. ADHD persists into adulthood in approximately 50% to 65% of cases, though presentation often shifts — overt hyperactivity tends to decrease while inattention, executive dysfunction, and emotional dysregulation often persist.

ADHD is highly comorbid. Up to 80% of individuals with ADHD have at least one additional psychiatric condition during their lifetime, most commonly anxiety disorders, depression, learning disorders, autism spectrum disorder, oppositional defiant disorder (in children), and substance use disorders. Comorbidity affects diagnosis, treatment selection, and outcomes.

Recent research has expanded understanding of ADHD beyond the classic hyperactive-presentation child. Adult ADHD, ADHD in women, and ADHD in individuals from underrepresented groups are increasingly recognized as historically underdiagnosed. Emotional dysregulation and rejection-sensitive dysphoria, while not formal DSM criteria, are increasingly understood as common features.

Untreated ADHD carries measurable costs: reduced educational and occupational attainment relative to ability, relationship difficulties, increased risk of accidents and injuries, higher rates of substance use, and elevated mental-health comorbidity. With evidence-based treatment — typically combining medication and behavioural or cognitive intervention — most individuals experience meaningful improvement in core symptoms and functioning.

Signs and symptoms

Inattention — Difficulty sustaining attention on tasks that are not intrinsically rewarding, frequent careless mistakes, and difficulty following multi-step instructions.
Distractibility — Easily diverted by external stimuli or internal thoughts, with difficulty returning to the original task once interrupted.
Difficulty with task initiation — Marked struggle to start tasks, particularly those that are non-preferred, complex, or have ambiguous starting points.
Time blindness — Difficulty estimating time passage, planning around deadlines, and pacing work appropriately, often resulting in chronic lateness or last-minute completion.
Working memory difficulty — Forgetting information mid-task, losing track of conversations, or losing items frequently despite organizational efforts.
Hyperactivity — In children, observable restlessness, excessive movement, talking, and difficulty staying seated. In adults, often experienced internally as a sense of being driven by a motor or unable to settle mentally.
Impulsivity — Acting without forethought, interrupting others, making decisions without weighing consequences, and difficulty delaying gratification.
Emotional dysregulation — Strong, rapid emotional reactions disproportionate to triggers, often described as "having no skin." Not in DSM criteria but consistently identified in clinical research.
Hyperfocus — Periods of intense, sustained attention on highly engaging activities, often at the expense of other obligations or self-care. A counterintuitive but characteristic feature.
Executive dysfunction — Difficulty with planning, prioritizing, sequencing, and self-monitoring complex tasks, even when the individual understands what needs to be done.

Diagnostic context

ADHD in the DSM-5-TR requires six or more symptoms (five for adults aged 17+) of inattention or hyperactivity-impulsivity persisting for at least six months and inconsistent with developmental level. Several symptoms must have been present before age 12 and across two or more settings (for example, home and school or home and work). Symptoms must cause clinically significant impairment and not be better explained by another mental disorder.

Diagnosis is made by a qualified clinician — typically a psychiatrist, psychologist, family physician with relevant training, or pediatrician — through structured clinical interview, behavioural observation, review of childhood history (often via parent report or school records), and rating scales. Common assessment instruments include the Conners Adult ADHD Rating Scale (CAARS), the Adult ADHD Self-Report Scale (ASRS), and the Brown Executive Function/Attention Scales. Computerized continuous performance tests (CPT) are sometimes used as adjunctive measures but are not diagnostic alone. Differential diagnosis includes anxiety disorders, mood disorders, sleep disorders, learning disorders, autism spectrum disorder, and substance-related conditions.

Causes and risk factors

ADHD is one of the most heritable psychiatric conditions, though environmental factors play a substantial modifying role.

Genetic and biological factors

Twin studies estimate heritability at approximately 70% to 80%, among the highest of any psychiatric condition. Multiple genes contributing small individual effects have been identified, particularly in dopaminergic and noradrenergic signaling pathways. Neuroimaging consistently shows differences in prefrontal cortex, basal ganglia, and cerebellar structure and function, with delayed cortical maturation in childhood ADHD that often catches up in adulthood.

Prenatal and perinatal factors

Prenatal alcohol exposure, maternal smoking during pregnancy, prematurity, low birth weight, and perinatal complications are associated with elevated ADHD risk. Recent research has refined some earlier associations, distinguishing causal effects from confounded family-history effects.

Environmental and developmental factors

Lead exposure, severe early deprivation, and chronic stress can produce ADHD-like presentations, though most cases are not environmentally caused. Nutritional factors, sleep, and screen time may modulate symptom expression but are not primary causes.

Comorbid contributors

Sleep disorders, thyroid conditions, learning disorders, and sensory processing differences can produce or amplify ADHD-like symptoms. Differential evaluation is important when symptoms emerge in adulthood without clear childhood history.

Typical treatments

ADHD is highly responsive to evidence-based treatment, typically combining medication and behavioural or cognitive intervention.

Pharmacotherapy. Stimulant medications (methylphenidate and amphetamine derivatives) are the most extensively studied and effective treatments, with response rates of 70% to 80%. Non-stimulant options (atomoxetine, guanfacine, clonidine) are used when stimulants are not tolerated or appropriate. Medication selection, titration, and monitoring should be done by a physician or psychiatrist with ADHD experience.

Cognitive behavioural therapy (CBT) for adult ADHD. Specialized CBT protocols address executive function, time management, organization, planning, and the secondary anxiety and depression that often accompany untreated ADHD. Several manualized protocols (Safren, Ramsay) have demonstrated efficacy, particularly in combination with medication.

Behavioural therapy for children. Parent training, classroom interventions, and behavioural strategies are first-line for children under 6 and important adjuncts for older children. Evidence-based programs include Parent-Child Interaction Therapy (PCIT) and behavioural parent training.

ADHD coaching and skills training. Structured coaching focused on executive function, organization, and goal-pursuit can be effective adjunctive treatment, particularly for adults navigating work and life-management challenges.

Lifestyle and adjunctive interventions. Regular aerobic exercise, sleep regularization, structured routines, and reduction of competing demands during high-focus tasks all support symptom management. They are not substitutes for primary treatment in moderate-to-severe ADHD.

Combined treatment. The MTA Study and subsequent research consistently show that combined medication and behavioural treatment outperforms either alone for most outcomes, particularly functional outcomes beyond core symptom reduction.

When to seek help

Professional consultation is warranted when attention, executive function, or activity level are causing measurable interference with school, work, relationships, or daily functioning, particularly when difficulties have been present since childhood. Adult-onset of ADHD-like symptoms warrants careful evaluation to rule out other causes (sleep disorders, thyroid conditions, mood disorders, substance effects).

In Canada, free 24-hour mental-health support is available through 9-8-8: Suicide Crisis Helpline (call or text 988). A general practitioner is an appropriate first contact and can refer to qualified psychologists, psychiatrists, or family physicians with ADHD assessment training. CADDRA (Canadian ADHD Resource Alliance) maintains practice guidelines and a clinician directory.

Frequently asked questions

Can ADHD be diagnosed in adulthood?

Yes. While DSM-5-TR criteria require some symptoms to have been present before age 12, many individuals are diagnosed for the first time in adulthood, often after coping strategies become inadequate (career advancement, parenthood, loss of structure). Adult diagnosis typically involves review of childhood history alongside current symptoms.

Is ADHD overdiagnosed?

Research suggests ADHD is both overdiagnosed in some populations and underdiagnosed in others. Boys with overt hyperactivity are more readily identified, while girls and adults with predominantly inattentive presentations have historically been underdiagnosed. Diagnostic accuracy depends on appropriately trained clinicians using structured assessment.

Are stimulant medications addictive?

When prescribed and used as directed, stimulant medications for ADHD have low rates of dependency. Research consistently shows that treated ADHD is associated with REDUCED risk of substance use disorders compared to untreated ADHD. Misuse risk is real and is managed through prescribing practices and monitoring.

What is rejection-sensitive dysphoria?

Rejection-sensitive dysphoria refers to intense emotional pain in response to perceived or actual rejection, criticism, or failure, commonly reported by individuals with ADHD. It is not a formal DSM diagnosis but is increasingly recognized as a clinically significant feature of ADHD-related emotional dysregulation.

Can ADHD coexist with anxiety or depression?

Yes. Up to 80% of individuals with ADHD have at least one comorbid psychiatric condition. Anxiety and depression are particularly common and may be primary or secondary to ADHD-related life difficulties. Treatment typically addresses comorbidities alongside or following ADHD treatment.

How long does treatment last?

ADHD is a chronic condition, and treatment is typically long-term. Many individuals adjust medication and supports over time as life circumstances change. Some adults reduce or discontinue medication during life phases that are well-suited to their cognitive style; others continue indefinitely. Treatment decisions are individualized.

References

Find the pattern behind what's been feeling hard

A few simple questions to help surface the concerns that may fit best.

Find Your Pattern

Therapy for ADHD

Connect with a ShiftGrit therapist at one of our locations:

Find a Therapist by Province

Browse therapy options by province to see which clinicians are available to work with clients in your region.

ADHD therapists in Alberta ADHD therapists in Ontario

Trusted by Leading Psychology & Mental Health Organizations Across Canada

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Trusted By Alberta’s Leading Psychology & Mental Health Organizations

ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.

Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.

Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.

Authored by

ShiftGrit Clinical Editorial Team

The ShiftGrit Clinical Editorial Team combines the insight of registered psychologists, provisional psychologists, and trained writers to create accessible, evidence-informed therapy resources. All content is clinically reviewed by a Registered Psychologist.